Federal Register / Vol. 72, No. 191 / Wednesday, October 3, 2007 / Notices 56365 

changes made to the PIN. Where 

comments do not result in a revision to 

the PIN, explanations will be provided. 

Background: HRSA has received 

numerous requests for clarification 

regarding the program guidelines, 

requirements, and application process 

for the FQHC Look-Alike program. The 

purpose of the FQHC Look-Alike PIN is 

to respond to these requests for 

clarification and to make the application 

process more consistent with section 

330 grant programs. 

The Omnibus Budget Reconciliation 

Acts of 1989, 1990, and 1993 amended 

section 1905 of the Social Security Act 

to create a new category of facility under 

Medicaid and Medicare known as 

Federally Qualified Health Centers 

(FQHCs). The Social Security Act 

§ 1905(l)(2)(B) definition of an FQHC 

included an entity which, based on the 

recommendation of HRSA, is 

determined to meet the requirements of 

the section 330 grant program but does 

not receive the grant. This category of 

health centers has been labeled FQHC 

Look-Alikes. 

To ensure that there are appropriate 

numbers of health centers to serve the 

millions of uninsured and underinsured 

populations throughout the country, 

FQHC Look-Alike status was made 

available to those entities that do not 

receive funding under section 330 but 

operate and provide services similar to 

grant-funded programs. As such, FQHC 

Look-Alikes are expected to 

demonstrate a commitment to serve all 

populations residing in their respective 

medically underserved communities 

regardless of their ability to pay and to 

satisfy all of the administrative, 

management, governance and servicerelated requirements that apply to 

section 330 funded health centers. 

Benefits of obtaining FQHC Look-Alike 

status include eligibility for enhanced 

Medicaid and Medicare reimbursement, 

participation in the 340(b) Federal Drug 

Pricing Program, and automatic Health 

Professional Shortage Area designation. 

HRSA is responsible for managing the 

FQHC Look-Alike program and 

submitting recommendations to the 

Centers for Medicare and Medicaid 

Services (CMS) for designation as 

FQHCs; however, CMS has the final 

authority to designate applicants as 

FQHCs. The organizations are 

recertified annually to assure they are in 

compliance with these regulations. 

FOR FURTHER INFORMATION CONTACT: For 

questions regarding this notice, please 

contact Cicely Nelson at (301) 594–

4496. 

Dated: September 24, 2007. 

Elizabeth M. Duke, 

Administrator. 

[FR Doc. E7–19507 Filed 10–2–07; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Director’s Council of Public 

Representatives. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Director’s Council of 

Public Representatives. 

Date: October 26, 2007. 

Time: 8:30 a.m. to adjournment. 

Agenda: Key topics for this meeting will 

focus on public engagement in the 

biomedical and behavioral research process. 

Further information will be available on the 

COPR Web site in mid-October at 

www.copr.nih.gov. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 9000 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Kelli L. Carrington, 

Executive Secretary/Public Liaison Officer, 

Office of Communications and Public 

Liaison, Office of the Director, National 

Institutes of Health, 9000 Rockville Pike, 

Building 1, Room 344, Bethesda, MD 20892, 

301–594–4575, carringk@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www.copr.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: September 26, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4864 Filed 10–2–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Clinical Trials 

Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Clinical Trials Advisory Committee. 

Date: November 14, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: Update on the progress of the 

implementation of the Clinical Trials 

Working Group. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Room 10, 

Bethesda, MD 20892. 

Contact Person: Sheila A. Prindiville, MD, 

Director, Coordinating Center for Clinical 

Trials, Office of the Director, National Cancer 

Institute, National Institutes of Health, 6120 

Executive Blvd., Suite 507, Bethesda, MD 

20892, 301–451–5048, 

prindivs@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 


rwilkins on PROD1PC63 with NOTICES
56366 Federal Register / Vol. 72, No. 191 / Wednesday, October 3, 2007 / Notices 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 26, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4862 Filed 10–2–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; The Role of Human 

Milk-Morrow—SEP. 

Date: October 19, 2007. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ramada Inn Rockville, 1775 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Rita Anand, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, NIH, 6100 

Executive Blvd., Room 5B01, Bethesda, MD 

20892, (301) 496–1487, 

anandr@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: September 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4863 Filed 10–2–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; MATHIAS–

P01. 

Date: October 25–26, 2007. 

Time: 6 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Ramesh Vemuri, PhD, 

Scientific Review Office, National Institute 

on Aging, National Institutes of Health, 7201 

Wisconsin Avenue, Suite 2C–212, Bethesda, 

MD 20892, 301–402–7700, rv23r@nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Sex 

Differences in Health and Longevity. 

Date: October 31–November 1, 2007. 

Time: 5 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites, Washington, DC 

20015. 

Contact Person: Wilbur C. Hadden, PhD, 

Health Science Administrator, National 

Institute on Aging, Gateway Building, Room 

2C–212, 7201 Wisconsin Avenue, Bethesda, 

MD 20892, haddenw@mail.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Bousfield 

Review Meeting. 

Date: November 6, 2007. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway, 7802 Wisconsin Avenue, 2C–212, 

Bethesda, MD 20895, (Telephone Conference 

Call). 

Contact Person: Ramesh Vemuri, PhD, 

Scientific Review Office, National Institute 

on Aging, National Institutes of Health, 7201 

Wisconsin Avenue, Suite 2C–212, Bethesda, 

MD 20892, 301–402–7700, rv23r@nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Health, 

Aging, and the Life-Course. 

Date: November 7, 2007. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Bethesda, MD 20770, (Telephone Conference 

Call). 

Contact Person: Wilbur C. Hadden, PhD, 

Health Science Administrator, National 

Institute on Aging, Gateway Building, Room 

2C–212, 7201 Wisconsin Avenue, Bethesda, 

MD 20892, haddenw@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: September 26, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4865 Filed 10–2–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Disease; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Allergy, Immunology, 

and Transplantation Research Committee, 

Allergy, Immunology and Transplantation 

Research Committee (AITRC). 

Date: October 25, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel and 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Katrin Eichelberg, PhD., 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, NIAID/NIH/DHHS, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892, (301) 496–0808, 

keichelberg@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 


rwilkins on PROD1PC63 with NOTICES